Wells Fargo Gives a Buy Rating to Cardinal Health (CAH)

In a report released today, Stephen Baxter from Wells Fargo assigned a Buy rating to Cardinal Health, with a price target of $256.00.

Claim 30% Off TipRanks

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Baxter is an analyst with an average return of -1.4% and a 42.59% success rate. Baxter covers the Healthcare sector, focusing on stocks such as Elevance Health, Cencora, and Community Health.

In a report released on April 8, Evercore ISI also maintained a Buy rating on the stock with a $240.00 price target.

Based on Cardinal Health’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $65.44 billion and a net profit of $471 million. In comparison, last year the company earned a revenue of $55.26 billion and had a net profit of $400 million

Based on the recent corporate insider activity of 45 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CAH in relation to earlier this year. Most recently, in February 2026, Aaron E Alt, the CFO of CAH sold 4,242.00 shares for a total of $947,556.06.